WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011140984) ANTI-HBV POLYPEPTIDE, PHARMACEUTICAL COMPOSITION AND USE THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/140984    International Application No.:    PCT/CN2011/073963
Publication Date: 17.11.2011 International Filing Date: 12.05.2011
IPC:
C07K 14/01 (2006.01), G01N 33/68 (2006.01), A61K 38/16 (2006.01), A61P 1/16 (2006.01), A61P 31/20 (2006.01)
Applicants: SHANGHAI HEP BIOTECH CO., LTD. [CN/CN]; Room 208, Building 1, 720 Cailun Road Shanghai 201203 (CN) (For All Designated States Except US).
LIU, Hongli [CN/CN]; (CN) (For US Only)
Inventors: LIU, Hongli; (CN)
Agent: SHANGHAI PATENT & TRADEMARK LAW OFFICE, LLC; 435 Guiping Road Shanghai 200233 (CN)
Priority Data:
201010174788.X 14.05.2010 CN
Title (EN) ANTI-HBV POLYPEPTIDE, PHARMACEUTICAL COMPOSITION AND USE THEREOF
(FR) POLYPEPTIDE ANTI-HBV, COMPOSITION PHARMACEUTIQUE ET UTILISATION ASSOCIÉES
(ZH) 抗HBV的多肽、其药物组合物及应用
Abstract: front page image
(EN)The invention provides peptides which can inhibit virus, especially HBV. The modification of the N terminus and C terminus of these peptides result in the improvement of polypeptides' stability and effectiveness. The invention also provides the use of these peptides in the prophylaxis and treatment of HBV infections.
(FR)La présente invention concerne des peptides qui peuvent inhiber un virus, notamment le HBV. La modification de l'extrémité N-terminale et de l'extrémité C-terminale de ces peptides résulte en l'amélioration de la stabilité et de l'efficacité des polypeptides. L'invention concerne également l'utilisation de ces peptides dans la prophylaxie et le traitement d'infections par le HBV.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)